Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Veit Rothhammer

12PUBLICATIONS
56CO-AUTHORS
Innate immunityAutoimmunityClinical chemistry (incl. diagnostics)Medical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Mar 26, 2026
Interferon-β and FTY720 ameliorate progressive CNS inflammation via SOCS1-associated astrocyte signaling.

Thanos Tsaktanis, Tobias Beyer, Lucy Nirschl

|Jan 08, 2026
Pearls & Oy-sters: Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia.

Alexander German, Alexander Grotemeyer, Veit Rothhammer

|Dec 23, 2025
Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Carolin Landt, Friederike Held, Konstantina Kolotourou

|Aug 26, 2025
Author Correction: Disease-associated astrocyte epigenetic memory promotes CNS pathology.

Hong-Gyun Lee, Joseph M Rone, Zhaorong Li

|Aug 05, 2025
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity.

Thanos Tsaktanis, Leander Ammon, Lena Lößlein

|Jun 19, 2025
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation.

Lena Lößlein, Mathias Linnerbauer, Finnja Zuber

Pageof 2

Frequent Collaborators

4 joint publications

Lena Lößlein

4 joint publications

Michael A Wheeler

4 joint publications

Francisco Quintana

3 joint publications

Lucas E Flausino

3 joint publications

Joseph M Rone

3 joint publications

Tomer Illouz

3 joint publications

Bernhard Hemmer

3 joint publications

Hong-Gyun Lee

3 joint publications

Chun-Cheih Chao

3 joint publications

Camilo Faust Akl

Frequent Collaborators

4 joint publications

Lena Lößlein

4 joint publications

Michael A Wheeler

4 joint publications

Francisco Quintana

3 joint publications

Lucas E Flausino

Top Related Videos

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:45

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on : Feb 24, 2026

230
An <em>In Vitro</em> Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An <em>In Vitro</em> Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on : Oct 21, 2014

8.3K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on : Sep 12, 2016

12.7K
See more related videos

Top Related Videos

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:45

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on : Feb 24, 2026

230
An <em>In Vitro</em> Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An <em>In Vitro</em> Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on : Oct 21, 2014

8.3K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on : Sep 12, 2016

12.7K
See more related videos